Portfolio comparison
Tianjin Genovo Biotechnology Co vs Novartis AG
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Tianjin Genovo Biotechnology Co
Patents indexed
1
Year range
2025
Most recent
2025
biotechagriculturegene_editing
Top Patents1 enriched
US 12416013· 2025
Boosting Plant Gene Editing and Regeneration with Special Genes
Activity by Decade
2020s1
Top Patents2 enriched
US 10472419· 2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
US 7740842· 2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Activity by Decade
2010s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.